[Federal Register Volume 62, Number 172 (Friday, September 5, 1997)]
[Notices]
[Page 47070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-23610]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
September 25-26, 1997. The meeting will take place at the address 
provided below. All sessions of the meeting will be open to the public, 
except where specifically noted otherwise.
    Topics of discussion will include: (1) An evaluation of the ACMUI 
and the composition of its membership; (2) an update on the revision of 
10 CFR part 35 and associated activities; (3) a discussion of the 
requirements for (a) a Quality Management Program, (b) a radiation 
safety committee, (c) training and experience, and (d) notification of 
patients; (4) a discussion of possible options for revising the 1979 
Medical Policy Statement; and (5) a discussion of previous ACMUI 
recommendations. Additionally, the staff will provide an update on 
several rulemakings and regulatory guides: (1) Rulemaking for part 33, 
``Specific Domestic Licenses of Broad Scope for Byproduct Material;'' 
(2) petition for rulemaking for carbon-14 use; (3) petition from the 
University of Cincinnati regarding 10 CFR 20.1301, and (4) 
radiopharmacy guidance.
    In addition, on September 25, 1997, from 8:00 a.m. to 8:30 a.m., 
there will be a closed session of the ACMUI to discuss ethics rules and 
their application. This session will be closed on the grounds that the 
meeting will relate solely to internal personnel rules and/or practices 
of the agency and will involve information the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

DATES: The meeting will begin at 8:30 a.m., on September 25, 1997, and 
8:00 a.m. on September 26, 1997.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 
11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION CONTACT: Diane Flack, U.S. Nuclear Regulatory 
Commission, Office of Nuclear Material Safety and Safeguards, MS T8F5, 
Washington, DC 20555, Telephone (301) 415-5681.

Conduct of the Meeting

    Judith Ann Stitt, M.D., will chair the meeting. Dr. Stitt will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Diane Flack (address listed previously), by 
September 18, 1997. Statements must pertain to the topics on the agenda 
for the meeting.
    2. At the meeting, questions from members of the public will be 
permitted at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection, and copying, for a fee, at the NRC Public Document Room, 
2120 L Street, N.W., Lower Level, Washington, DC 20555, telephone (202) 
634-3273, on or about October 3, 1997. Minutes of the meeting will be 
available on or about November 14, 1997.
    4. Seating for the public will be on a first-come, first-served 
basis.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, part 7.

    Dated: August 29, 1997.
Kenneth R. Hart,
Acting Secretary of the Commission.
[FR Doc. 97-23610 Filed 9-4-97; 8:45 am]
BILLING CODE 7590-01-P